Physician profile
Dennis Cesar
NPI 1861685786
$6,579.03
in general payments reported to CMS, 2019-2025
35 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $284 · 2021: $1,080 · 2022: $860 · 2023: $1,209 · 2024: $1,877 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,529 · Education: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,528.96 |
| Education | $349.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $811.27 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $597.51 | 2019-2024 | Provenge |
| Janssen Biotech, INC. | $576.55 | 2021-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $454.11 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $421.87 | 2019-2025 | |
| Abbvie INC. | $409.85 | 2019-2025 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $384.72 | 2022-2024 | Prolaris, Myrisk |
| Urovant Sciences INC | $349.86 | 2021-2022 | |
| Antares Pharma, INC. | $284.35 | 2021-2025 | Xyosted |
| Accord Healthcare, INC. | $283.44 | 2024-2025 | |
| Boston Scientific Corporation | $280.66 | 2019-2024 | Rezum Generator, Ams 700 |
| Urogen Pharma, INC. | $279.15 | 2021-2024 | Jelmyto |
| Dornier Medtech America, INC | $183.72 | 2023 | Dornier Medtech |
| Ferring Pharmaceuticals INC. | $164.73 | 2019-2025 | Adstiladrin |
| Myovant Sciences INC. | $157.10 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $153.37 | 2023-2024 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $92.98 | 2021-2022 | |
| Teleflex LLC | $83.97 | 2021-2023 | Urolift |
| Pfizer INC. | $79.02 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $69.38 | 2022-2025 | Imfinzi, Lynparza |
| Tolmar, INC. | $65.82 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.32 | 2020-2022 | |
| Axonics, INC. | $54.43 | 2020-2024 | Axonics |
| Merck Sharp & Dohme LLC | $45.08 | 2024 | Keytruda |
| Olympus America INC. | $36.40 | 2021-2024 | Itind System |
| Novartis Pharmaceuticals Corporation | $34.07 | 2024 | |
| Allergan, INC. | $26.71 | 2021 | |
| Halozyme INC | $26.11 | 2023 | |
| Karl Storz Endoscopy-America | $19.98 | 2024 | N.A. |
| 180 Medical, INC. | $18.94 | 2022 | |
| Immunitybio, INC. | $17.28 | 2024 | |
| Convatec INC. | $14.84 | 2024 | |
| Dentsply Ih Ab | $14.55 | 2023 | Lofric |
| Laborie Medical Technologies Corp. | $14.48 | 2024 | Eclipse |
| Neotract INC. | $13.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Cesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.